FDA Decision Dooms Cancer Patients

FDA Decision Dooms Cancer Patients
The American Spectator
By Robert Goldberg
July 1, 2011

Opponents of medical progress are celebrating the decision of a Food and Drug Administration panel to revoke approval of the use of Avastin in treating advance breast cancer.

Not so fast.

Read the full article here.

Featured

Animal health and human health are inextricably linked

May 15, 2012

Drug Shortages and the Role of the Middle Man

April 13, 2012

Obamacare's Medical Mercenaries

April 13, 2012

Social Networks

Receive latest news & event updates
Provide email below:

	Like CMPI on Facebook
	Follow CMPI on Twitter
	Connect with CMPI on LinkedIn
	Watch our Videos on CMPI YouTube Channel
	Subscribe to Receive CMPI RSS Feeds

Donate

Please consider a tax-deductible contribution to CMPI. Your support is appreciated.

Support CMPI >>